Exploring immunotherapy in colorectal cancer

Chemotherapy combined with or without targeted therapy is the fundamental treatment for metastatic colorectal cancer (mCRC). Due to the adverse effects of chemotherapeutic drugs and the biological characteristics of the tumor cells, it is difficult to make breakthroughs in traditional strategies. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Weng, Junyong, Li, Shanbao, Zhu, Zhonglin, Liu, Qi, Zhang, Ruoxin, Yang, Yufei, Li, Xinxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288068/
https://www.ncbi.nlm.nih.gov/pubmed/35842707
http://dx.doi.org/10.1186/s13045-022-01294-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9288068/
https://www.ncbi.nlm.nih.gov/pubmed/35842707
http://dx.doi.org/10.1186/s13045-022-01294-4

Ejemplares similares